# Olympus to acquire BioProtect for $270M

Olympus Corporation has signed a definitive agreement to acquire BioProtect Ltd., a medical device manufacturer, for $270 million. The acquisition is expected to close by the end of Q2 2026.

- Type: Acquisition
- Announced: 2026-05-26
- Value: $270.0M
- Status: announced
- Products: Balloon Spacer system for prostate cancer radiation therapy
- Sectors: [Medical Devices](https://endata.com/sectors/medical-devices.md)

## Companies

- [Olympus](https://endata.com/companies/30528.md) (acquirer)
- [BioProtect Ltd.](https://endata.com/companies/92136.md) (target)

## Sources

- [prnewswire.com](https://www.prnewswire.com/news-releases/olympus-to-acquire-bioprotect-to-expand-its-portfolio-of-urological-technologies-and-address-prostate-cancer-302781571.html), 2026-05-26: "Olympus, a global MedTech company committed to advancing endoscopy-enabled care, announced today it has signed a definitive agreement to acquire BioProtect Ltd."
- [olympusamerica.com](https://olympusamerica.com/press-release/2026-05-26/olympus-acquire-bioprotect-expand-its-portfolio-urological-technologies), 2026-05-26: "The $270 million acquisition, with certain amounts held in escrow for a period dependent on uninterrupted operation of the business, is expected to be completed by the end of the second quarter of calendar year 2026."

---
Data from Endata (https://endata.com/). Announcements are summarized from public sources and may be incomplete; check the linked originals.